Zomedica Corp. (NASDAQ:ZOM) | WebDisclosure

Basculer en Français

9480	Companies
185558	Keywords
117947	Articles
99388	Press releases

Home
Companies
Zomedica Corp.

PRESS RELEASE

published on 04/01/2024 at 22:05, 1 year 8 months ago

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Zomedica Corp. reports consolidated financial results for Q4 and full year 2023, showing significant revenue growth and progress. CEO Larry Heaton highlights momentum and strategic acquisitions for future growth

Financial Results Revenue Growth Acquisitions 2023 Zomedica Corp.
BRIEF

published on 03/20/2024 at 11:35, 1 year 8 months ago

Zomedica Announces Q4 and Full Year 2023 Financial Results Conference

Financial Results Conference Call 2023 Performance Zomedica Veterinary Health
BRIEF

published on 03/20/2024 at 11:35, 1 year 8 months ago

Zomedica annonce la conférence sur les résultats financiers du quatrième trimestre et de l'exercice 2023

Résultats Financiers Zomedica Conférence Téléphonique Santé Vétérinaire Performances 2023
PRESS RELEASE

published on 03/20/2024 at 11:30, 1 year 8 months ago

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals

Financial Results Conference Call Companion Animals Zomedica Corp. Veterinary Health
BRIEF

published on 03/14/2024 at 11:35, 1 year 8 months ago

Zomedica's TRUFORMA Demonstrates Superior Accuracy in Feline Hyperthyroidism Diagnosis Over CLIA Platforms

Zomedica TRUFORMA Hyperthyroidism Veterinary Research Diagnostic Technology
BRIEF

published on 03/14/2024 at 11:35, 1 year 8 months ago

TRUFORMA de Zomedica démontre une précision supérieure dans le diagnostic de l'hyperthyroïdie féline par rapport aux plateformes CLIA

Zomedica TRUFORMA Hyperthyroïdie Recherche Vétérinaire Technologie Diagnostique
PRESS RELEASE

published on 03/14/2024 at 11:30, 1 year 8 months ago

Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Zomedica Corp. announced the publication of a peer-reviewed research study comparing its TRUFORMA BAW diagnostic platform to CLIA platforms for feline hyperthyroidism diagnosis, showing superior accuracy and potential for early detection

Zomedica Corp. TRUFORMA BAW Diagnostic Platform Feline Hyperthyroidism Peer-reviewed Research Study
BRIEF

published on 03/13/2024 at 21:50, 1 year 8 months ago

Zomedica Provides NYSE American Listing Update

Reverse Stock Split Compliance Zomedica Share Price NYSE American
BRIEF

published on 03/13/2024 at 21:50, 1 year 8 months ago

Zomedica fournit une mise à jour de la cotation américaine au NYSE

Zomedica Conformité Cours De L'action NYSE Américain Regroupement D'actions
PRESS RELEASE

published on 03/13/2024 at 21:45, 1 year 8 months ago

Zomedica Provides NYSE American Listing Update
Zomedica Corp. announces ongoing dialogue with NYSE American regarding compliance with listing standards. Shares to remain listed as Company explores options

Compliance Zomedica Corp. Share Price NYSE American Listing Standards

Accesswire

Published on 12/05/2025 at 21:45, 20 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 35 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 45 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 5 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 1 hour 40 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 3 hours 7 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 3 hours 38 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 3 hours 49 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 4 hours 13 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 4 hours 18 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 4 hours 47 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 4 hours 47 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 6 hours 54 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 6 hours 54 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 6 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE